Land: Canada
Sprog: engelsk
Kilde: Health Canada
BETA-CAROTENE; VITAMIN E (DL-ALPHA TOCOPHERYL ACETATE); ASCORBIC ACID (ASCORBIC ACID); VITAMIN B1 (THIAMINE MONONITRATE); VITAMIN B2 (RIBOFLAVIN); NICOTINAMIDE; VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE); D-PANTOTHENIC ACID (CALCIUM D-PANTOTHENATE); MAGNESIUM (MAGNESIUM OXIDE); IODINE (POTASSIUM IODIDE); IRON (FERROUS FUMARATE); COPPER (CUPRIC OXIDE); ZINC (ZINC OXIDE); FOLIC ACID; VITAMIN B12 (CYANOCOBALAMIN); VITAMIN D3 (CHOLECALCIFEROL); CALCIUM (CALCIUM CARBONATE)
DUCHESNAY INC
B03AE04
IRON, MULTIVITAMINS AND MINERALS
1.6MG; 13.8MG; 120MG; 3MG; 3.4MG; 20MG; 10MG; 5MG; 50MG; 0.15MG; 35MG; 2MG; 15MG; 1.1MG; 12MCG; 250UNIT; 300MG
TABLET
BETA-CAROTENE 1.6MG; VITAMIN E (DL-ALPHA TOCOPHERYL ACETATE) 13.8MG; ASCORBIC ACID (ASCORBIC ACID) 120MG; VITAMIN B1 (THIAMINE MONONITRATE) 3MG; VITAMIN B2 (RIBOFLAVIN) 3.4MG; NICOTINAMIDE 20MG; VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE) 10MG; D-PANTOTHENIC ACID (CALCIUM D-PANTOTHENATE) 5MG; MAGNESIUM (MAGNESIUM OXIDE) 50MG; IODINE (POTASSIUM IODIDE) 0.15MG; IRON (FERROUS FUMARATE) 35MG; COPPER (CUPRIC OXIDE) 2MG; ZINC (ZINC OXIDE) 15MG; FOLIC ACID 1.1MG; VITAMIN B12 (CYANOCOBALAMIN) 12MCG; VITAMIN D3 (CHOLECALCIFEROL) 250UNIT; CALCIUM (CALCIUM CARBONATE) 300MG
ORAL
60
Prescription
VITAMINS & MINERALS
Active ingredient group (AIG) number: 1747661008; AHFS:
CANCELLED POST MARKET
2016-07-05
_ _ _PregVit_ _®_ _ and PregVit folic 5_ _®_ _Product Monograph _ _Page 1 of 38 _ _ _ _ _ PRODUCT MONOGRAPH Vitamin-Mineral Supplement Tablets For Prenatal/Postpartum Use DIN 02246067 Vitamin-Mineral Supplement Tablets High Dose Folic Acid for Prenatal Use DIN 02276194 Multivitamins and other Minerals Including Combinations Duchesnay Inc. 2925 boul. Industriel Laval, Quebec Canada, H7L 3W9 duchesnay.com © 2009 by Duchesnay Inc. SUBMISSION CONTROL NUMBER: 121647 - 121649 Patents: Canada 2,478,163, US D501,252 Other Patents Pending US, Canada and other countries © Duchesnay Inc. 2004-2009 DATE OF REVISION: JANUARY 7, 2009 _ _ _ _ _PregVit_ _®_ _ and PregVit folic 5_ _®_ _Product Monograph _ _Page 2 of 38 _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ TABLE OF CONTENTS PART I: HEALTH PROFESSIONAL INFORMATION......................................................... 3 SUMMARY PRODUCT INFORMATION ..............................................................................................................3 INDICATIONS AND CLINICAL USE....................................................................................................................4 CONTRAINDICATIONS .........................................................................................................................................5 WARNINGS AND PRECAUTIONS........................................................................................................................5 ADVERSE REACTIONS .........................................................................................................................................7 DRUG INTERACTIONS........................................................................................................................................10 DOSAGE AND ADMINISTRATION....................................................................................................................15 OVERDOSAGE .............................................................................................................................. Læs hele dokumentet